PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.96%
Revenue growth above 1.5x M7U.DE's 3.69%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.44%
Gross profit growth under 50% of M7U.DE's 29.42%. Michael Burry would be concerned about a severe competitive disadvantage.
141.21%
EBIT growth above 1.5x M7U.DE's 28.89%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
133.19%
Operating income growth above 1.5x M7U.DE's 29.03%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
116.53%
Net income growth above 1.5x M7U.DE's 24.27%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
116.41%
EPS growth above 1.5x M7U.DE's 26.47%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
116.41%
Diluted EPS growth above 1.5x M7U.DE's 26.47%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.50%
Dividend growth of 9.50% while M7U.DE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-23.68%
Negative OCF growth while M7U.DE is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-22.64%
Negative FCF growth while M7U.DE is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
67.14%
10Y revenue/share CAGR under 50% of M7U.DE's 241.40%. Michael Burry would suspect a lasting competitive disadvantage.
31.65%
5Y revenue/share CAGR similar to M7U.DE's 32.18%. Walter Schloss might see both companies benefiting from the same mid-term trends.
1.98%
3Y revenue/share CAGR under 50% of M7U.DE's 10.34%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.79%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
56.28%
Net income/share CAGR at 75-90% of M7U.DE's 67.47%. Bill Ackman would press for strategic moves to boost long-term earnings.
-4.30%
Negative 5Y net income/share CAGR while M7U.DE is 32.82%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-66.67%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
142.29%
Equity/share CAGR of 142.29% while M7U.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
105.17%
Below 50% of M7U.DE's 523.79%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
71.57%
Below 50% of M7U.DE's 190.17%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while M7U.DE shows 16.10%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
5.28%
Inventory shrinking or stable vs. M7U.DE's 13.32%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.81%
Asset growth well under 50% of M7U.DE's 12.14%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.05%
Under 50% of M7U.DE's 22.93%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.24%
We’re deleveraging while M7U.DE stands at 17.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-14.19%
We cut SG&A while M7U.DE invests at 75.61%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.